Denali Therapeutics, Inc. (DNLI)

20.44 -0.49 (-2.34%) USD  |  NASDAQ  |  Jan 23, 13:31
More

Denali Therapeutics Proceeds from Stock Option Exercised (Annual)

Proceeds from Stock Option Exercised (Annual) Chart

View Proceeds from Stock Option Exercised (Annual) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Annual) Benchmarks

View Proceeds from Stock Option Exercised (Annual) Benchmarks
Start Trial
Enovis Corp. Upgrade
Masimo Corp. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
AIM ImmunoTech, Inc. Upgrade